| 1 |
33088620 | Quantile-dependent expressivity of plasma adiponectin concentrations may explain its sex-specific heritability, gene-environment interactions, and genotype-specific response to postprandial lipemia. | 2020 |
1 |
| 2 |
30192654 | Dexamethasone decreases the autotaxin-lysophosphatidate-inflammatory axis in adipose tissue: implications for the metabolic syndrome and breast cancer. | 2019 Feb |
1 |
| 3 |
30897345 | Rosiglitazone-dependent dissociation of HuR from PPAR-γ regulates adiponectin expression at the posttranscriptional level. | 2019 Jun |
5 |
| 4 |
30307150 | miR-876-3p regulates glucose homeostasis and insulin sensitivity by targeting adiponectin | 2018 Oct 1 |
1 |
| 5 |
28588299 | Protective effect of rosiglitazone on kidney function in high-fat challenged human-CRP transgenic mice: a possible role for adiponectin and miR-21? | 2017 Jun 6 |
1 |
| 6 |
28867378 | Autologous fat transplants to deliver glitazone and adiponectin for vasculoprotection. | 2017 Oct 28 |
3 |
| 7 |
28962190 | Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus. | 2017 Sep |
5 |
| 8 |
27077672 | Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation. | 2016 Mar |
4 |
| 9 |
25595190 | Dexamethasone and rosiglitazone are sufficient and necessary for producing functional adipocytes from mesenchymal stem cells. | 2015 Sep |
1 |
| 10 |
24890138 | Impact of rosiglitazone on body composition, hepatic fat, fatty acids, adipokines and glucose in persons with impaired fasting glucose or impaired glucose tolerance: a sub-study of the DREAM trial. | 2014 Sep |
3 |
| 11 |
23081744 | Influence of Tyrphostin AG490 on the expression of diabetes-associated markers in human adipocytes. | 2013 Jan |
1 |
| 12 |
23286943 | Attenuation of islet-specific T cell responses is associated with C-peptide improvement in autoimmune type 2 diabetes patients. | 2013 Feb |
1 |
| 13 |
23358729 | Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis. | 2013 Jan |
1 |
| 14 |
24178343 | Adiponectin decreases lipids deposition by p38 MAPK/ATF2 signaling pathway in muscle of broilers. | 2013 Dec |
4 |
| 15 |
22809900 | Mitochondrial dysfunction and activation of iNOS are responsible for the palmitate-induced decrease in adiponectin synthesis in 3T3L1 adipocytes. | 2012 Sep 30 |
1 |
| 16 |
20814411 | Eicosapentaenoic acid and rosiglitazone increase adiponectin in an additive and PPARγ-dependent manner in human adipocytes. | 2011 Feb |
3 |
| 17 |
21031343 | Effects of rosiglitazone/metformin fixed-dose combination therapy and metformin monotherapy on serum vaspin, adiponectin and IL-6 levels in drug-naïve patients with type 2 diabetes. | 2011 Feb |
2 |
| 18 |
21863614 | Pharmacogenetics of oral antidiabetic treatment. | 2011 |
3 |
| 19 |
20180607 | Pharmacodynamic effects of rosiglitazone in nondiabetic patients with metabolic syndrome. | 2010 Mar |
3 |
| 20 |
20415685 | The role of adiponectin in the pathogenesis and treatment of non-alcoholic fatty liver disease. | 2010 May |
1 |
| 21 |
20484463 | Peroxisome proliferator-activated receptor-gamma increases adiponectin secretion via transcriptional repression of endoplasmic reticulum chaperone protein ERp44. | 2010 Jul |
1 |
| 22 |
20506517 | Rosiglitazone inhibits monocyte/macrophage adhesion through de novo adiponectin production in human monocytes. | 2010 Aug 15 |
7 |
| 23 |
19074982 | Functional characterization of promoter variants of the adiponectin gene complemented by epidemiological data. | 2009 Apr |
1 |
| 24 |
19322744 | The effect of rosiglitazone on insulin sensitivity, beta cell function, bone mineral density, and body composition in hiv-positive patients on highly-active antiretroviral therapy (HAART). | 2009 Jul |
1 |
| 25 |
19368716 | Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies. | 2009 Apr 15 |
5 |
| 26 |
19394661 | Impact of rosiglitazone and glyburide on nitrosative stress and myocardial blood flow regulation in type 2 diabetes mellitus. | 2009 Jul |
1 |
| 27 |
19622782 | Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans. | 2009 Sep |
1 |
| 28 |
19690066 | A rosiglitazone-induced increase in adiponectin does not improve glucose metabolism in HIV-infected patients with overt lipoatrophy. | 2009 Nov |
4 |
| 29 |
19812444 | Combined effect of C-reactive protein and stavudine on adipogenesis. | 2009 |
1 |
| 30 |
18068701 | Characterization of lipid metabolism in insulin-sensitive adipocytes differentiated from immortalized human mesenchymal stem cells. | 2008 Feb 15 |
1 |
| 31 |
18254722 | Importance of the high-molecular-mass isoform of adiponectin in improved insulin sensitivity with rosiglitazone treatment in HIV disease. | 2008 Sep |
3 |
| 32 |
18307460 | Beneficial effects of rosiglitazone on novel cardiovascular risk factors in patients with Type 2 diabetes mellitus. | 2008 Mar |
2 |
| 33 |
18392690 | Arterial elasticity and plasma levels of adiponectin and leptin in type 2 diabetic patients treated with thiazolidinediones. | 2008 Feb |
1 |
| 34 |
18429970 | The association of adiponectin allele 45T/G and -11377C/G polymorphisms with Type 2 diabetes and rosiglitazone response in Chinese patients. | 2008 Jun |
7 |
| 35 |
18541328 | The effect of rosiglitazone on oxidative stress and insulin resistance in overweight individuals. | 2008 Aug |
1 |
| 36 |
18841263 | A randomized, controlled trial of the effects of rosiglitazone on adipokines, and inflammatory and fibrinolytic markers in diabetic patients: study design and protocol. | 2008 Oct |
1 |
| 37 |
18942491 | Impact of rosiglitazone on visfatin and adiponectin plasma concentrations in patients with type 2 diabetes and coronary artery disease. | 2008 |
3 |
| 38 |
18958842 | Rosiglitazone, but not glimepiride, improves myocardial diastolic function in association with reduction in oxidative stress in type 2 diabetic patients without overt heart disease. | 2008 Nov |
1 |
| 39 |
17084402 | Adiponectin is associated with improvement of endothelial function after rosiglitazone treatment in non-diabetic individuals with metabolic syndrome. | 2007 Nov |
2 |
| 40 |
17087601 | Effect of PPAR-gamma agonist treatment on markers of endothelial dysfunction in patients with type 2 diabetes mellitus. | 2007 |
2 |
| 41 |
17148967 | Effects of metformin and rosiglitazone in HIV-infected patients with hyperinsulinemia and elevated waist/hip ratio. | 2007 Jan 2 |
1 |
| 42 |
17192324 | Rosiglitazone in diabetes control in hemodialysis patients with and without viral hepatitis infection: effectiveness and side effects. | 2007 Jan |
1 |
| 43 |
17200362 | Pilot study of rosiglitazone therapy in women with breast cancer: effects of short-term therapy on tumor tissue and serum markers. | 2007 Jan 1 |
1 |
| 44 |
17224000 | Effects of rosiglitazone and metformin on inflammatory markers and adipokines: decrease in interleukin-18 is an independent factor for the improvement of homeostasis model assessment-beta in type 2 diabetes mellitus. | 2007 Feb |
1 |
| 45 |
17287417 | Rosiglitazone treatment increases plasma levels of adiponectin and decreases levels of resistin in overweight women with PCOS: a randomized placebo-controlled study. | 2007 Feb |
3 |
| 46 |
17641277 | C-reactive protein inhibits adiponectin gene expression and secretion in 3T3-L1 adipocytes. | 2007 Aug |
3 |
| 47 |
17761896 | Isoginkgetin enhances adiponectin secretion from differentiated adiposarcoma cells via a novel pathway involving AMP-activated protein kinase. | 2007 Sep |
1 |
| 48 |
17805239 | Rosiglitazone decreases albuminuria in type 2 diabetic patients. | 2007 Dec |
1 |
| 49 |
17889553 | The potential insulin sensitizing and glucose lowering effects of a novel indole derivative in vitro and in vivo. | 2007 Oct |
2 |
| 50 |
17892035 | [The effect of rosiglitazone on plasma adiponectin and resistin levels in obese PCO woman--preliminary report]. | 2007 |
2 |